Recombinant 2019-nCoV Spike S1 Antibody, Human Chimeric
Beta LifeScience
SKU/CAT #: BLSN-009M
Recombinant 2019-nCoV Spike S1 Antibody, Human Chimeric
Beta LifeScience
SKU/CAT #: BLSN-009M
Collections: Antibodies
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Host Species | 2019-nCoV |
Synonym | SARS-CoV-2 S1 RBD Antibody, 2019-nCoV Spike S1 Antibody,COVID-19 Spike S1 Antibody |
Background | 2019 Novel Coronavirus (2019-nCoV) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. |
Description | 2019-nCoV Spike S1 Antibody, Human Chimeric is produced from cell culture in vitro under conditions free from animal-derived components. |
Source | In vitro |
Formulation | 2019-nCoV Spike S1 antibody is supplied in PBS, pH 7.4, containing 0.02% sodium azide. |
Stability | This product is stable for 1 year at -20°C |
Applications | ELISA: 0.1-10 µg/ml |
Clone | GB-1990 |
Specificity | 2019-nCoV Spike S1 Antibody is specific for COVID-19 Spike Protein S1 subunit and its RBD domain. |
Isotype | Recombinant human IgG1 |
Concentration | 1mg/mL |
Usage | For Research Use Only |
Storage | Store at -20°C. Avoid repeated freezing and thawing cycles. |